Articles


Why Marine Omega-3s?


Mood & Mind Health


Joint Health


Pre- and Postnatal Health


Eye Health


Cognitive Health


Cardiovascular Health


Healthy Inflammation Response

 

Metabolic Syndrome 

 

Other

 
 
EPAX News & Events

Epax phase-3 study builds base for continued expansion into pharmaceutical omega-3 segment

Epax AS continues expansion into the pharmaceutical omega-3 segment with study
on AKR963 successfully achieving phase 3 study efficacy endpoints.

Read Press Release

 
 

EPAX Announces Corporate Restructuring

The Omega-3 lipids corporation previously formed by Trygg Pharma and former EPAX AS will be named EPAX AS. Former EPAX AS will become Epax Norway AS, a fully owned subsidiary and the key operating company of the Epax group.

Read press release

 
 

EPAX again honored as top supplier by Banner Pharmacaps.

EPAX AS was recognized for on-time deliveries and high quality standards.

Read press release

 
 
EPAX AS
PO Box 2047
NO-6028 Aalesund, Norway

Site Map        Disclaimer

© Copyright 2008  EPAX AS

Tlf: +47 70 13 59 60
Fax: +47 70 13 59 61
E-mail: epax@epax.com
sales@epax.com